Charles Webb, DO
Sports Medicine · Shreveport, LANPI 1811967235
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 46 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 20.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $574, 5.2 times the $111 reported in 2019. That places this record below the midpoint for sports medicine clinicians in LA, where the typical reported total is $3,045.
Across 46 payments — averaging $21.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$199
- Steelhead Surgical Inc$111
- Novo Nordisk$100
- Dexcom, Inc.$67
- Ultragenyx Pharmaceutical Inc.$67
- Inspire Medical Systems, Inc.$65
- plus $370 from 15 others
What the payments were for
- Food & beverage$980100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 16 | $199 |
| Steelhead Surgical Inc | 1 | $111 |
| Novo Nordisk | 6 | $100 |
| Dexcom, Inc. | 3 | $67 |
| Ultragenyx Pharmaceutical Inc. | 1 | $67 |
| Inspire Medical Systems, Inc. | 1 | $65 |
| Lilly USA, LLC | 3 | $56 |
| Bioventus LLC | 1 | $54 |
| AstraZeneca | 2 | $39 |
| Ferring Pharmaceuticals Inc. | 1 | $27 |
| Abiomed | 1 | $25 |
| Innovation Technologies Inc | 1 | $24 |
| Lundbeck LLC | 1 | $18 |
| Midsouth Orthopedics Inc. | 1 | $18 |
| Exact Sciences | 1 | $17 |
| Ardelyx, Inc. | 1 | $17 |
| Pfizer | 1 | $16 |
| Smith+Nephew | 1 | $16 |
| Abbott | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Axsome Therapeutics, Inc. | 1 | $14 |
How this compares
$980 in reported general payments places this provider in the 35th percentile of 82 sports medicine providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 52 | $72,385 |
| OzempicSemaglutide | 60 | $69,795 |
| EliquisApixaban | 14 | $15,674 |
| TrulicityDulaglutide | 11 | $12,499 |
| Diclofenac Sodium | 75 | $2,149 |
| Gabapentin | 74 | $1,314 |
| Rosuvastatin Calcium | 37 | $906 |
| Nifedipine ErNifedipine | 29 | $900 |
| Ventolin HfaAlbuterol Sulfate | 11 | $693 |
| Pantoprazole Sodium | 41 | $605 |
| Losartan Potassium | 76 | $595 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 16 | $589 |
| Atorvastatin Calcium | 90 | $560 |
| Omeprazole | 36 | $449 |
| Tamsulosin Hcl | 33 | $395 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $56 | $84,88463 claims |
| Novo NordiskOzempic | $100 | $69,79560 claims |
| PfizerEliquis | $16 | $15,67414 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 82 sports medicine providers in Louisiana.
Other sports medicine in Shreveport
- Mario Lobao GoncalvesShreveport$32K
- Kyle PlanchardShreveport$29K
- George ByramShreveport$14K
- Richard BartonShreveport$9K
- Carlton HoutzShreveport$3K
- Naina Bouchereau-LalShreveport$1K
- Felix SavoieNew Orleans$1.4M
- Misty SuriNew Orleans$1.2M
- Michael ObrienNew Orleans$391K
- Brett CascioLake Charles$82K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.